-
1.TREATMENT OF MELANOMA WITH INTERFERON-BETA AND RAS-RAF-MEK-ERK INHIBITOR COMBINATION THERAPY 审中-公开
Title translation: 用干扰素和RAS-RAF-MEK-ERK抑制剂组合治疗的梅毒的治疗公开(公告)号:US20160228513A1
公开(公告)日:2016-08-11
申请号:US14884530
申请日:2015-10-15
Applicant: BIOGEN MA INC.
Inventor: Darren P. BAKER , Ingrid B.J.K. JOSEPH , Xinzhong WANG
IPC: A61K38/21 , A61K31/166 , A61K47/48 , A61K31/436 , A61K31/44 , A61K31/337 , A61K31/4188 , A61K39/395
CPC classification number: A61K38/215 , A61K31/166 , A61K31/337 , A61K31/4188 , A61K31/436 , A61K31/44 , A61K39/3955 , A61K45/06 , A61K47/60 , A61K2039/505 , A61K2300/00 , C07K16/22 , C07K2317/24 , C07K2317/76
Abstract: This description relates to the use of a polymer-conjugated interferon-beta as monotherapy or in combination with other cancer therapies.
Abstract translation: 该描述涉及聚合物缀合的干扰素-β作为单一疗法或与其它癌症治疗组合的用途。